DexCom earnings beat by $0.03, revenue topped estimates
LONDON - Physiomics plc (AIM: PYC), a company specializing in mathematical modeling and data science for drug development and personalized medicine, has announced its intention to raise up to £70,000 through a retail offer. The offer, made via the Winterflood Retail Access Platform (WRAP), involves issuing up to 14 million new ordinary shares at a price of £0.005 each.
This retail offer is exclusively available to existing shareholders in the United Kingdom (TADAWUL:4280) and complements a separate placing of new ordinary shares aimed at raising approximately £500,000 before expenses. The placing shares, along with the retail offer shares, are collectively referred to as the New Ordinary Shares and are being offered at the same price as the retail offer shares.
The placing price of £0.005 per share represents a 37.5% discount to the mid-market closing price of an ordinary share as of February 12, 2025. The proceeds from both the retail offer and the placing are intended to be used in the same manner, although specific details on the use of proceeds were not disclosed in the press release.
The retail offer is open to eligible investors who are existing shareholders of Physiomics plc as of today or will become shareholders before placing an order for the retail offer shares. The offer is expected to close at 11:00 a.m. on February 17, 2025, but potential participants are advised to be aware of earlier closing times set by financial intermediaries.
Admission of the New Ordinary Shares to trading on AIM is conditional upon the completion of the placing. Trading is anticipated to commence on or around 8:00 a.m. on February 18, 2025.
Physiomics emphasizes the importance of its retail shareholder base and the opportunity this offer provides for their participation. Minimum subscription per investor is set at £100, and terms and conditions, including commission or fee charges, will be provided by the relevant financial intermediaries. The company reserves the right to amend the size of the retail offer and to scale back or reject any application without explanation.
Investors are reminded that once an application for retail offer shares has been made and accepted, it cannot be withdrawn. The New Ordinary Shares, once issued, will rank equally in all respects with the existing ordinary shares.
The offer is being conducted under the exemption from the requirement to publish a prospectus, according to section 86(1)(e) of the Financial Services and Markets Act 2000 (FSMA). This announcement is based on a press release statement and is intended for informational purposes only. It does not constitute an offer, invitation, or solicitation to buy or subscribe for securities of Physiomics PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.